Physician profile
Peter A Rienzo
NPI 1033166285
$379.14
in general payments reported to CMS, 2019-2025
10 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43.88 · 2020: $47.04 · 2021: $38.57 · 2022: $18.29 · 2023: $29.69 · 2024: $94.98 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $231.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $231.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $131.79 | 2021-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Depuy Synthes Sales INC. | $69.30 | 2019-2020 | |
| Ebi, LLC | $49.38 | 2025 | Biomet Ebi Bone Healing System |
| Abbvie INC. | $33.17 | 2024 | |
| Highridge Medical LLC | $27.79 | 2025 | Biomet Ebi Bone Healing System |
| Pacira Pharmaceuticals Incorporated | $18.09 | 2024 | Zilretta, Iovera, Exparel |
| Nevro Corp. | $17.59 | 2020 | |
| Zimvie INC. | $16.96 | 2023 | |
| Heron Therapeutics, INC. | $11.04 | 2021 | |
| Si-Bone, INC. | $4.03 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Rienzo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.